Prothena (NASDAQ:PRTA) Given Underperform Rating at Bank of America
Prothena (NASDAQ:PRTA – Get Free Report)‘s stock had its “underperform” rating reiterated by stock analysts at Bank of America in a note issued to investors on Wednesday, MarketBeat.com reports. PRTA has been the topic of a number of other reports. Wall Street Zen upgraded Prothena from a “sell” rating to a “hold” rating in a […]
Prothena (NASDAQ:PRTA – Get Free Report)‘s stock had its “underperform” rating reiterated by stock analysts at Bank of America in a note issued to investors on Wednesday, MarketBeat.com reports. PRTA has been the topic of a number of other reports. Wall Street Zen upgraded Prothena from a “sell” rating to a “hold” rating in a […]
